Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DCTHNASDAQ:LUCDNASDAQ:OSANASDAQ:RCLF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDCTHDelcath Systems$13.85-2.2%$14.43$7.17▼$18.23$482.40M0.94390,525 shs699,443 shsLUCDLucid Diagnostics$1.26$1.28$0.71▼$1.80$136.32M1.31603,797 shs3.05 million shsOSAProSomnus$0.41$0.35▼$5.25$237K0.2165,686 shs5 shsRCLFRosecliff Acquisition Corp I$11.06$8.96▼$19.50$78.49M0.0264,402 shs150,200 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDCTHDelcath Systems0.00%-9.71%-14.03%-0.79%+71.84%LUCDLucid Diagnostics0.00%-2.33%-20.75%-16.00%+81.84%OSAProSomnus0.00%0.00%0.00%0.00%+36.00%RCLFRosecliff Acquisition Corp I0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDCTHDelcath Systems2.9248 of 5 stars3.55.00.00.00.62.50.6LUCDLucid Diagnostics3.4553 of 5 stars3.65.00.00.03.21.70.6OSAProSomnusN/AN/AN/AN/AN/AN/AN/AN/ARCLFRosecliff Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDCTHDelcath Systems 3.00Buy$24.0073.29% UpsideLUCDLucid Diagnostics 3.20Buy$3.55181.75% UpsideOSAProSomnus 0.00N/AN/AN/ARCLFRosecliff Acquisition Corp I 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest DCTH, LUCD, OSA, and RCLF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025LUCDLucid DiagnosticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.50 ➝ $7.755/23/2025DCTHDelcath SystemsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $29.005/15/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.005/14/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.004/21/2025LUCDLucid DiagnosticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.00 ➝ $7.504/11/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.003/26/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.003/25/2025LUCDLucid DiagnosticsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$2.003/24/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$2.50 ➝ $3.00(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDCTHDelcath Systems$37.21M12.96N/AN/A$2.15 per share6.44LUCDLucid Diagnostics$4.35M31.34N/AN/A($0.78) per share-1.62OSAProSomnus$27.65M0.00N/AN/A($2.33) per share0.00RCLFRosecliff Acquisition Corp IN/AN/AN/A8.27($2.13) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDCTHDelcath Systems-$26.39M-$0.50N/AN/AN/A-26.38%-29.44%-20.75%8/4/2025 (Estimated)LUCDLucid Diagnostics-$45.53M-$1.34N/AN/AN/A-1,699.86%N/A-124.27%8/11/2025 (Estimated)OSAProSomnus-$24.09M-$1.56N/AN/AN/A-87.14%N/A-106.30%N/ARCLFRosecliff Acquisition Corp I$11.04MN/A0.00N/AN/AN/A-1.62%0.31%N/ALatest DCTH, LUCD, OSA, and RCLF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025DCTHDelcath Systems$0.10$0.03-$0.07$0.03$16.83 million$19.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDCTHDelcath SystemsN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/AOSAProSomnusN/AN/AN/AN/AN/ARCLFRosecliff Acquisition Corp IN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDCTHDelcath SystemsN/A15.9514.61LUCDLucid DiagnosticsN/A0.750.74OSAProSomnusN/A1.000.86RCLFRosecliff Acquisition Corp IN/A0.110.11Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDCTHDelcath Systems61.12%LUCDLucid Diagnostics74.01%OSAProSomnus70.03%RCLFRosecliff Acquisition Corp I3.23%Insider OwnershipCompanyInsider OwnershipDCTHDelcath Systems17.94%LUCDLucid Diagnostics6.80%OSAProSomnus7.70%RCLFRosecliff Acquisition Corp I0.41%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDCTHDelcath Systems6034.83 million28.58 millionOptionableLUCDLucid Diagnostics70108.19 million100.83 millionNo DataOSAProSomnus13617.39 million16.06 millionNot OptionableRCLFRosecliff Acquisition Corp I36.78 million6.76 millionNot OptionableDCTH, LUCD, OSA, and RCLF HeadlinesRecent News About These CompaniesVertex Technology Acquisition Corporation Ltd. (VT1.SI)December 8, 2023 | sg.finance.yahoo.comDistoken Acquisition Corporation (NASDAQ:DIST) is largely controlled by institutional shareholders who own 59% of the companyNovember 7, 2023 | finance.yahoo.comSPAC Rosecliff shareholders approve merger with Spectral MDSeptember 8, 2023 | msn.comPre-market Movers: GROM, DMS, RCLF, PLTN, SPRB…September 8, 2023 | markets.businessinsider.comWhy Is Rosecliff Acquisition (RCLF) Stock Down 17% Today?September 8, 2023 | msn.comRosecliff Acquisition Corp I (NASDAQ: RCLF)August 19, 2023 | fool.comFiling of Updated Form S-4 by Rosecliff & Updated Investor PresentationAugust 15, 2023 | pharmiweb.comDefinitive Proxy Statement and Prospectus Mailed by Rosecliff Acquisition Corporation IAugust 15, 2023 | pharmiweb.comUpdated Investor Presentation & Filing by Rosecliff Acquisition Corp. IAugust 1, 2023 | pharmiweb.comRosecliff Acquisition Corp I Class AJuly 15, 2023 | morningstar.comSpectral MD Holdings, Ltd ("Spectral MD" or the "Company") Announces Publication of Peer Reviewed Proof-of-Concept Study Evaluating DeepView® Technology in Journal of Burn Care & ResearchJune 13, 2023 | finance.yahoo.comSpectral MD Announces Podium Presentation at 2023 American Burn Association Annual ConferenceMay 18, 2023 | finance.yahoo.comSpectral MD Holdings, Ltd. $4.0 Million Grant Award from the Medical Technology Enterprise ConsortiumApril 18, 2023 | finance.yahoo.comSpectral MD to list on Nasdaq via SPAC merger with RosecliffApril 11, 2023 | msn.comSpectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp IApril 11, 2023 | finance.yahoo.comRosecliff Acquisition Corp. I Cl AJanuary 21, 2023 | wsj.comTastemaker Acquisition Corp. (NASDAQ:TMKR) is largely controlled by institutional shareholders who own 68% of the companyOctober 15, 2022 | yahoo.comRosecliff Acquisition Stock (NASDAQ:RCLFU), Analyst Ratings, Price Targets, PredictionsOctober 9, 2022 | benzinga.comRosecliff Acquisition Corp I (RCLFW)September 13, 2022 | finance.yahoo.comRosecliff Acquisition Corp I (RCLF)July 2, 2022 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingIran Conflict Fuels Fertilizer Stocks’ Bullish SetupBy Gabriel Osorio-Mazilli | June 16, 2025View Iran Conflict Fuels Fertilizer Stocks’ Bullish SetupDCTH, LUCD, OSA, and RCLF Company DescriptionsDelcath Systems NASDAQ:DCTH$13.85 -0.31 (-2.19%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$14.45 +0.60 (+4.33%) As of 06/20/2025 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.Lucid Diagnostics NASDAQ:LUCD$1.26 0.00 (0.00%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.26 0.00 (0.00%) As of 06/20/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.ProSomnus NASDAQ:OSAProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.Rosecliff Acquisition Corp I NASDAQ:RCLFRosecliff Acquisition Corp I does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Rosecliff Acquisition Corp I was incorporated in 2020 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
